Deals
Coherus Biosciences Raises $10M at 1% Discount From Baxalta
|
Coherus Biosciences (NASDAQ GM:CHRS) announced that it has raised $9,999,980 in a Common Stock transaction.
Growth Capitalist (https://growthcapitalist.com/author/aislaks/page/126/)
Coherus Biosciences (NASDAQ GM:CHRS) announced that it has raised $9,999,980 in a Common Stock transaction.
Blue Earth (NASDAQ CM:BBLU) announced that it has raised $10,600,000 in a Non-Convertible Senior Secured Notes transaction
True Drinks Holdings (OTC:TRUU) announced that it has raised $2,500,000 in a Non-Convertible Senior Subordinated Secured Notes transaction.
BioTime (AMEX:BTX) announced that it has raised $8,578,349 in a Registered Direct transaction.